-
PDF
- Split View
-
Views
-
Cite
Cite
Regina Schuhegger, Majse Nafisi, Madina Mansourova, Bent Larsen Petersen, Carl Erik Olsen, Aleš Svatoš, Barbara Ann Halkier, Erich Glawischnig, CYP71B15 (PAD3) Catalyzes the Final Step in Camalexin Biosynthesis, Plant Physiology, Volume 141, Issue 4, August 2006, Pages 1248–1254, https://doi.org/10.1104/pp.106.082024
Close - Share Icon Share
Abstract
Camalexin represents the main phytoalexin in Arabidopsis (Arabidopsis thaliana). The camalexin-deficient phytoalexin deficient 3 (pad3) mutant has been widely used to assess the biological role of camalexin, although the exact substrate of the cytochrome P450 enzyme 71B15 encoded by PAD3 remained elusive. 2-(Indol-3-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid (dihydrocamalexic acid) was identified as likely intermediate in camalexin biosynthesis downstream of indole-3-acetaldoxime, as it accumulated in leaves of silver nitrate-induced pad3 mutant plants and it complemented the camalexin-deficient phenotype of a cyp79b2/cyp79b3 double-knockout mutant. Recombinant CYP71B15 heterologously expressed in yeast catalyzed the conversion of dihydrocamalexic acid to camalexin with preference of the (S)-enantiomer. Arabidopsis microsomes isolated from leaves of CYP71B15-overexpressing and induced wild-type plants were capable of the same reaction but not microsomes from induced leaves of pad3 mutants. In conclusion, CYP71B15 catalyzes the final step in camalexin biosynthesis.
Camalexin (3-thiazol-2′-yl-indole), originally isolated from Camelina sativa (Browne et al., 1991), is the main phytoalexin of the model plant Arabidopsis (Arabidopsis thaliana; Tsuji et al., 1992). Its formation has been studied in detail as part of the highly sophisticated network of plant defense reactions, including hypersensitive response after interaction with incompatible pathogens (for review, see Kliebenstein, 2004; Glazebrook, 2005). Camalexin has been shown to inhibit growth of particular plant pathogens, e.g. Alternaria brassicicola or some Botrytis cinerea isolates, while others remain unaffected (Rogers et al., 1996; Thomma et al., 1999; Ferrari et al., 2003; Kliebenstein et al., 2005).
The camalexin biosynthetic pathway. Cys-R, Cys or Cys derivative.
So far five phytoalexin deficient mutants (pad1–pad5) have been isolated in a screen for mutants with reduced camalexin content (Glazebrook and Ausubel, 1994; Glazebrook et al., 1997). Having consistently low camalexin levels independent of the inducing pathogen or abiotic treatment, pad3 has been widely used to investigate the role of camalexin in various Arabidopsis-pathogen interactions (Glazebrook and Ausubel, 1994; Thomma et al., 1999; Roetschi et al., 2001; Ferrari et al., 2003; Mert-Türk et al., 2003; Bohman et al., 2004). The corresponding PAD3 gene that was identified by positional cloning encodes for the cytochrome P450 enzyme CYP71B15 (Zhou et al., 1999). This suggested a function as camalexin biosynthetic gene (Zhou et al., 1999), or that CYP71B15 plays an indirect regulatory role, similar to MAX1, a regulatory P450 enzyme involved in flavonoid biosynthesis (Lazar and Goodman, 2006). Recently, 2-(indol-3-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid (dihydrocamalexic acid) was shown to accumulate in infected pad3 root cultures and was suggested as intermediate in camalexin biosynthesis (Bednarek et al., 2005).
In this article, we demonstrate that CYP71B15, expressed heterologously in yeast, catalyzes the conversion of dihydrocamalexic acid to camalexin. The same reaction was obtained with Arabidopsis microsomes isolated from untreated 35S∷CYP71B15 and induced wild-type leaves, but not from silver nitrate-induced pad3 plants. In conclusion, CYP71B15 catalyzes the final step in camalexin biosynthesis (Fig. 1).
RESULTS
Dihydrocamalexic Acid Accumulates in Induced pad3 Leaves and Complements the Camalexin-Deficient Phenotype of the cyp79b2/cyp79b3 Knockout Mutant
LC-MS analysis of dihydrocamalexic acid in methanol extracts of rosette leaves of pad3 and wild-type plants 18 h after silver nitrate spraying. A and B, Extracted ion chromatogram (m/z = 247) of wild type (A) and pad3 mutants (B) leaf extract is shown. C, Dihydrocamalexic acid standard. One of three independent experiments with comparable results is presented.
cyp79b2/cyp79b3 knockout mutants (Zhao et al., 2002) are camalexin deficient due to their inability to synthesize the intermediate IAOx (Glawischnig et al., 2004). When silver nitrate-treated cyp79b2/cyp79b3 rosette leaves were incubated in a 100 μm solution of (S)-dihydrocamalexic acid, wild-type levels (11.6 ± 4.8 μg g−1) of camalexin were synthesized. This shows that dihydrocamalexic acid is a precursor for camalexin. The enantiomer (R)-dihydrocamalexic acid (100 μm), derived from nonproteinogenic d-Cys, also was converted to camalexin but to a lesser extent (4.2 ± 0.6 μg g−1). Only minor camalexin formation in comparison to background level (0.1–0.2 μg g−1) was observed when pad3 mutants were incubated with either enantiomer (approximately 0.5 μg g−1), indicating that PAD3 (CYP71B15) is involved in the conversion of (S)-dihydrocamalexic acid to camalexin.
Dihydrocamalexic Acid Is the Substrate of CYP71B15
Analysis of CYP71B15 activity. A, HPLC profile with fluorescence detection after enzymatic conversion of (S)-dihydrocamalexic acid to camalexin by microsomes from yeast expressing CYP71B15 in the presence and absence of NADPH, or from yeast vector control (with NADPH). The product identity was confirmed by UV spectroscopy (B) and electron ionization MS spectrometry (C).
Kinetic properties of CYP71B15. The conversion of the (S)- and (R)-enantiomer of dihydrocamalexic acid to camalexin by microsomes of yeast expressing CYP71B15 (A) and Arabidopsis (B) was determined for different substrate concentrations. Substrate turnover (pmol mg−1 min−1) is plotted against substrate concentration (μm). Squares, (S)-enantiomer; circles, (R)-enantiomer.
Arabidopsis Microsomes Are Capable of the Same Enzymatic Conversions
Camalexin formation from (S)-dihydrocamalexic acid by Arabidopsis microsomes. Camalexin formation was compared from microsomes of wild type, 35S∷CYP71B15, and pad3 mutant. Left, Fluorescence chromatogram (using microsomes of the named genotypes with and without 16 h silver nitrate induction). For all preparations, NADPH-independent background was observed. Right, NADPH-dependent enzymatic activity of the six preparations (designated left, each average of three tests).
A Km of approximately 26.7 ± 2.5 μm was determined for this reaction by Col-0 microsomes (Fig. 4B). For the (R)-enantiomer, an apparent Km of 67.7 ± 3.6 μm was determined and the catalytic efficiency was approximately 36% in comparison to the (S)-enantiomer, which clearly shows the preference for the assumed natural substrate originated from conjugation with l-Cys.
CYP71B15 Expression Is Locally Induced in Leaves and Roots
Analysis of CYP71B15 expression in CYP71B15p∷GUS plants. A to E, GUS staining after challenging leaves with droplets of A. alternata spore suspension (A), P. syringae DC3000/Rps4 cell suspension (C), and 5 mm silver nitrate solution (E). Localized CYP71B15 induction was observed. Corresponding control treatments with buffer are shown in B and D, respectively, indicating that tween-containing buffer induces a minor CYP71B15 induction. Scale bars = 2 mm. F to H, GUS staining in roots, untreated (F and G) or 16 h after challenging with 5 mm silver nitrate (H). Scale bars = 0.2 mm.
DISCUSSION
We have demonstrated that CYP71B15 (PAD3) catalyzes the final step in camalexin biosynthesis. Large data sets exist on CYP71B15 induction upon infection with camalexin-inducing pathogens and abiotic treatments (Zhou et al., 1999; Glazebrook et al., 2003; Eulgem et al., 2004; Glawischnig et al., 2004; https://www.genevestigator.ethz.ch). We showed that CYP71B15 expression is induced locally, which is in accordance with its role in the biosynthesis of a phytoalexin. This expression pattern matches accumulation of camalexin and expression of other biosynthetic genes (Schuhegger et al., 2006) indicating that the whole biosynthetic pathway is colocalized and no transport of a biosynthetic intermediate occurs.
The pad3 mutant has been a valuable tool to study the effect of camalexin on pathogen growth. Being mutated in the last biosynthetic step with the precursor dihydrocamalexic acid still being synthesized, it is now clear that the enhanced susceptibilities of pad3 are the specific results of camalexin deficiency. In some cases where no enhanced susceptibility of pad3 is observed, the effect of dihydrocamalexic acid accumulation might mask the effect of camalexin deficiency. Dihydrocamalexic acid is an intermediate in camalexin biosynthesis and, in addition, is released from roots (Bednarek et al., 2005), where it possibly exhibits antimicrobial activity in the soil. This suggests that, in roots, all enzymes of the dihydrocamalexic acid-forming metabolon are tightly coregulated, but that PAD3 is regulated independently. Similar to pad3, the pad5 mutant also releases elevated amounts of dihydrocamalexic acid into the soil (Bednarek et al., 2005). In contrast to PAD3, the PAD5 protein, which remains to be identified, is unlikely to be involved in the conversion of dihydrocamalexic acid to camalexin, as yeast-expressed PAD3 (CYP71B15) is fully functional. Possible functions of PAD5 include regulation of PAD3 or integrity of a camalexin biosynthetic metabolon at the level of dihydrocamalexic acid.
PAD3 belongs to the large CYP71B family of P450 genes consisting of 37 members (Werck-Reichhart et al., 2002). The pad3 mutant synthesizes only minor amounts of camalexin, which shows that no other expressed CYP71B enzyme efficiently catalyzes the same reaction. A search for gene expression data revealed that most CYP71B genes are not significantly expressed. Only a few were markedly induced after pathogen challenge or under abiotic stress (e.g. CYP71B6, CYP71B7, and CYP71B20; Narusaka et al., 2004; https://www.genevestigator.ethz.ch). These expressed genes showed less than 60% identity to CYP71B15 on the amino acid level. As there are a number of examples of plant P450 enzymes with higher homology catalyzing different enzymatic reactions, it is not surprising that none of these genes can complement the pad3 mutant phenotype.
Proposed mechanism for CYP71B15. The pentavalent oxoiron in the reaction center initially abstracts a hydrid ion from C-5 of the thiazole ring. The formed intermediate liberates carbon dioxide in a fast spontaneous process forming a C-4/C-5 double bond.
The camalexin biosynthetic pathway from IAOx to dihydrocamalexic acid remains to be resolved. In analogy to indole glucosinolate biosynthesis, it has been hypothesized that the IAOx-metabolizing step is catalyzed by a cytochrome P450 enzyme (Glawischnig et al., 2004). The product of this reaction is unknown. Indole-3-carbaldehyde has been suggested to condensate with Cys in the camalexin biosynthetic pathway (Zook and Hammerschmidt, 1997). This intermediate remains speculative, as external application of indole-3-carbaldehyde did not complement the camalexin-deficient phenotype of the cyp79b2/cyp79b3 knockout mutant (E. Glawischnig, unpublished data). In bacteria, the introduction of thiazoline rings into secondary products is catalyzed by nonribosomal peptide synthetases with Cys as substrate (for review, see Crosa and Walsh, 2002). As no nonribosomal peptide synthetase genes have been described in Arabidopsis, the challenging task remains to demonstrate to which family the enzyme belongs that condensates the indolic and Cys-related intermediate and to identify the corresponding gene(s).
MATERIALS AND METHODS
Plant Material and Growth Conditions
Arabidopsis (Arabidopsis thaliana) ecotype Col-0 and pad3 plants were obtained from Lehle Seeds and the Nottingham Arabidopsis Stock Center, respectively. Plants were grown in soil mixed with sand (3:1) in a growth chamber at 12/12-h photoperiod at 80 to 100 μmol m−2 s−1, 21°C, and 40% relative humidity.
Generation and Analysis of CYP71B15-Overexpressing Plants
The CYP71B15 gene (At3g26830) was PCR amplified, sequenced, and cloned into the binary plant transformation vector pCAMBIA2300 under the control of 35S promoter (for details, see http://www.cambia.org). Agrobacterium-mediated transformation of Arabidopsis Col-0 plants was performed using the floral-dipping method, and successful transformation was confirmed by kanamycin resistance of the seedlings and by PCR analysis. RNA extraction and cDNA synthesis has been described by Schuhegger et al. (2006). Quantitative real-time PCR was performed with the CyberGreen/Light Cycler system (Roche) using the following primers: Actin1, tggaactggaatggttaaggctgg/tctccagagtcgagcacaataccg; and CYP71B15, gatctcggacatatttgtagcag/acccatcgcataaacgttgact. Camalexin extraction from leaf material has been described previously (Glawischnig et al., 2004).
Generation of CYP71B15p∷GUS Plants and GUS Analysis
A 2.9-kb promoter region of CYP71B15 was PCR amplified with the primer pair gaattcgcgctcttatactgtggctatatatgttatagac/cgccatggtccttgccctgttcttgtgttt and cloned into pGEM-T Easy (Promega) according to the manufacturer's instructions. The fragment was then excised and inserted into the GUS reporter vector pCAMBIA 1305.1 (for details, see http://www.cambia.org). Hygromycin-resistant transformants were selected and checked for positive GUS staining. GUS staining after silver nitrate spraying or challenge with Pseudomonas syringae or Alternaria alternata, respectively, was performed as described previously (Glawischnig et al., 2004; Schuhegger et al., 2006).
Synthesis of Dihydrocamalexic Acid
For (−)-(4S)-enantiomer, a solution of 1H-indole-3-carbonitrile (40 mg, 0.28 mmol) in degassed MeOH (2 mL) was added to l-Cys (150 mg) dissolved in MeOH (1 mL), phosphate buffer (pH 8, 1 mL). Powdered NaHCO3 (130 mg) was added and the reaction mixture was stirred at 77°C for 4 d under argon atmosphere. After cooling to ambient temperature, solvents were removed on a rotary evaporator. The residue was mixed with NaHCO3 solution (8% [w/v], 10 mL) and washed with ethyl acetate (2 × 10 mL). The aqueous phase was acidified with 2 m HCl to pH 3, and extracted into ethyl acetate (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over Na2SO4, and concentrated in vacuum. The product was obtained after crystallization from a hexane-ethyl acetate mixture as a beige-rose powder (50 mg, 72%).
1H NMR (CD3OD, 400 MHz): δ = 8.40 (1H, s, indol-H-2), 8.02 (1H, s, indol-H-4), 7.62 (1H, d, indol-H-7, J = 8 Hz), 7.40 (2H, m, indol-H-5,6), 5.40 (1H, m, CH-4), 3.95 (1H, dd, J = 11 Hz, 9 Hz, CH-5a), 3.80 (1H, dd, J = 11 Hz, 8 Hz, CH-5b). Electron ionization MS: (m/z, relative intensities) 246 (M +, 24), 201 (M +.-COOH, 100), 160 (23), 144 (63), 142 (68), 115 (28). [α]58920 −55 (0.2, MeOH); [α]58920 −50 (0.2, H2O).
For (+)-(4R)-enantiomer, the optical isomer (11 mg) was prepared from d-Cys hydrate hydrochloride as described above. Electron ionization MS: (m/z, relative intensities) 246 (M +, 24), 201 (M +.-COOH, 100), 160 (23), 144 (63), 142 (68), 115 (28). [α]58920 +50 (0.2, MeOH); [α]58920 +45 (0.2, H2O).
Mass Spectroscopy
Electron ionization and high-resolution mass spectra were obtained on a MasSpec 2 instrument (Micromass) in positive ion mode using 70-eV ionization energy and direct insertion probe. Perfluorokerosine mixture was used as an internal standard. For GC-high-resolution MS, analyses were performed with a Hewlett-Packard HP6890 gas chromatograph interfaced to a MasSpec 2. Separation was achieved on a J&W Scientific DB-5 capillary column, 30 m × 0.25 mm, 0.25-μm film thickness using helium (30 mL s−1) as carrier gas.
In Vivo Feeding
The camalexin-deficient cyp79b2/cyp79b3 knockout and pad3 mutants were sprayed with 5 mm silver nitrate to test complementation of the pathway with dihydrocamalexic acid. After 8 h, rosette leaves were cut at the petiole and incubated in 100 μL of 100 μm (S)- or (R)-dihydrocamalexic acid for an additional 16 h.
Metabolite Profiling
Leaf material (200 mg) was harvested 18 or 24 h after silver nitrate spraying and frozen in liquid nitrogen. The samples were kept at −80°C until processing. For extraction, the leaves were ground in liquid nitrogen, 1 mL of 50% aqueous MeOH (v/v) was added, and the samples were centrifuged for 15 min at 20,000g. The pellets were re-extracted with 600 μL of 50% MeOH, centrifuged again, and the supernatants were combined. The solvent was removed using a Speed-Vac and the residue was redissolved in 80% aqueous MeOH (1 μL per 5 mg initial fresh weight). The solutions were filtered through a 0.22-μm filter (Millipore) and LC-MS was performed as done by Glawischnig et al. (2004). For specific monitoring of dihydrocamalexic acid, extracted ion chromatograms (m/z = 247) were analyzed.
Yeast Expression, Arabidopsis Microsomes, and Product Analysis
Using recombinant PCR and the primer sets actggatccatggctgttttcctctgtttcctcgtc/caatccctgctacaaatatgtccgagatcattcctttgagatgatc and gatcatctcaaaggaatgatctcggacatatttgtagcagggattg/tacgaattctcagtggtgaagaacttgaaaga, corresponding to exon 1 and 2, respectively, on Arabidopsis ecotype Col-0 genomic DNA, a PCR fragment of the coding region of CYP71B15 was obtained and cloned into the binary vector pYeDP60 (Pompon et al., 1996), using the 5′ and 3′ restriction sites BamHI and EcoRI, respectively. The insert was sequenced to exclude PCR errors. Transformation of the yeast Saccharomyces cerevisiae WAT11, yeast growth, and microsomal preparations were performed according to the method of Pompon et al. (1996).
Arabidopsis microsomes were prepared using a modified protocol from Du et al. (1995). Approximately 1.2 g of rosette leaves untreated or 16 h after spraying with 5 mm AgNO3 were ground with sea sand and Polyclar AT in ice-cold extraction buffer (100 mm ascorbate, 1 mm EDTA, 5 mm dithiothreitol, 100 mm Tris, 20% [w/v] Suc, 20% [v/v] glycerol, pH 7.5), 20 mL g−1 FW, and centrifuged twice 15,000g, 10 min. The supernatant was centrifuged at 200.000g for 40 min. Then the pellet was resuspended in 50 mm KPi, 1 mm dithiothreitol, 20% (v/v) glycerol; centrifuged at 200,000g for 40 min; and resuspended in 1.5 mL of the same buffer.
Enzyme tests with yeast and Arabidopsis microsomes were performed for 30 min at 25°C in 200 μL of 50 mm Tris, pH 7.5 ± 1 mm NADPH, 20 μg microsomal protein, and 200 μm substrate (variable concentration for Km determination), extracted twice with 1 vol of ethyl acetate, which was then evaporated under reduced pressure. The pellet was redissolved in ethanol and analyzed for camalexin by HPLC. Samples were analyzed by reverse-phase HPLC (LiChroCART 250-4, RP-18, 5 μm [Merck]; 1 mL min−1; MeOH/water [1:1; v/v] for 2 min, followed by a 10-min linear gradient to 100% MeOH, followed by 3 min 100% MeOH). The peak at 10.6 min was identified as camalexin by comparison with authentic standard with respect to retention time and UV spectrum (photodiode array detector; Dionex) and quantified using a Shimadzu F-10AXL fluorescence detector (318 nm excitation, 370 nm emission) and by UV absorption at 318 nm. To confirm the identity of the product, the corresponding HPLC peak was collected, the MeOH was evaporated, and the remaining water phase was extracted with ethyl acetate and analyzed by GC-MS.
ACKNOWLEDGMENTS
We thank Prof. A. Gierl for his continuous support, Dr. Y. Zhao for providing cyp79b2/cyp79b3 knockout mutants, and Dr. P. Bednarek for helpful suggestions.
LITERATURE CITED
Bednarek P, Schneider B, Svatos A, Oldham NJ, Hahlbrook K (
Bohman S, Staal J, Thomma BP, Wang M, Dixelius C (
Browne LM, Conn KL, Ayer WA, Tewari JP (
Crosa JH, Walsh CT (
Du L, Lykkesfeldt J, Olsen CE, Halkier BA (
Eulgem T, Weigman VJ, Chang H-S, McDowell JM, Holub EB, Glazebrook J, Zhu T, Dangl JL (
Ferrari S, Plotnikova JM, De Lorenzo G, Ausubel FM (
Fukuda H, Fujii T, Sukita E, Tazaki M, Nagahama S, Ogawa T (
Glawischnig E, Hansen BG, Olsen CE, Halkier BA (
Glazebrook J (
Glazebrook J, Ausubel FM (
Glazebrook J, Chen W, Estes B, Chang HS, Nawrath C, Metraux JP, Zhu T, Katagiri F (
Glazebrook J, Zook M, Mert F, Kagan I, Rogers EE, Crute IR, Holub EB, Hammerschmidt R, Ausubel FM (
Kliebenstein DJ (
Kliebenstein DJ, Rowe HC, Denby KJ (
Lazar G, Goodman HM (
Mert-Türk F, Bennet MH, Mansfield JW, Holub EB (
Narusaka Y, Narusaka M, Seki M, Umezawa T, Ishida J, Nakajima M, Enju A, Shinozaki K (
Pompon D, Louerat B, Bronine A, Urban P (
Roetschi A, Si-Ammour A, Belbahri L, Mauch F, Mauch-Mani B (
Rogers EE, Glazebrook J, Ausubel FM (
Schuhegger R, Rauhut T, Glawischnig E (
Thomma BP, Nelissen I, Eggermont K, Broekaert WF (
Tsuji J, Jackson EP, Gage DA, Hammerschmidt R, Somerville SC (
Werck-Reichhart D, Bak S, Paquette S (
Zhao Y, Hull AK, Gupta NR, Goss KA, Alonso J, Ecker JR, Normanly J, Chory J, Celenza JL (
Zhou N, Tootle TL, Glazebrook J (
Author notes
This work was supported by the Deutsche Forschungsgemeinschaft (GL346/1) and the Max-Planck Gesellschaft.
Corresponding author; e-mail egl@wzw.tum.de; fax 49–8161–71–5636.
The author responsible for distribution of materials integral to the findings presented in this article in accordance with the policy described in the Instructions for Authors (www.plantphysiol.org) is: Erich Glawischnig (egl@wzw.tum.de).
Article, publication date, and citation information can be found at www.plantphysiol.org/cgi/doi/10.1104/pp.106.082024.






